Propanc Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PPCB and other ETFs, options, and stocks.About PPCB
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm focuses on the treatment of pancreatic, ovarian, and colorectal cancer.
CEOJames Andrew Nathanielsz
CEOJames Andrew Nathanielsz
Employees2
Employees2
HeadquartersCamberwell, Victoria (VIC)
HeadquartersCamberwell, Victoria (VIC)
Founded2007
Founded2007
Employees2
Employees2
PPCB Key Statistics
Market cap10.87M
Market cap10.87M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume474.18K
Average volume474.18K
High today$1.03
High today$1.03
Low today$0.7621
Low today$0.7621
Open price$0.8096
Open price$0.8096
Volume1.13M
Volume1.13M
52 Week high$145.46
52 Week high$145.46
52 Week low$0.73
52 Week low$0.73
Stock Snapshot
Propanc Biopharma(PPCB) stock is priced at $0.77, giving the company a market capitalization of 10.87M. It carries a P/E multiple of -0.02.
As of 2025-12-05, Propanc Biopharma(PPCB) stock has fluctuated between $0.76 and $1.03. The current price stands at $0.77, placing the stock +1.4% above today's low and -25.0% off the high.
Propanc Biopharma(PPCB) shares are trading with a volume of 1.13M, against a daily average of 474.18K.
In the last year, Propanc Biopharma(PPCB) shares hit a 52-week high of $145.46 and a 52-week low of $0.73.
In the last year, Propanc Biopharma(PPCB) shares hit a 52-week high of $145.46 and a 52-week low of $0.73.
People also own
Based on the portfolios of people who own PPCB. This list is generated using Robinhood data, and it’s not a recommendation.